INS and type 2 diabetes mellitus: Subjects with mild-to-moderate AD and T2DM were divided into two groups, according to antidiabetic pharmacotherapy: Patients treated with oral antidiabetic drugs (group A), and patients treated with insulin combined with other oral antidiabetic medications (group B).